Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Venkata Buddharaju"'
Publikováno v:
Human Pathology: Case Reports, Vol 8, Iss C, Pp 31-34 (2017)
Externí odkaz:
https://doaj.org/article/6b917040c3634acc88f4d4ad5fe28570
Publikováno v:
Cureus.
Publikováno v:
Cureus
Renal artery stenosis (RAS) is one of the major causes of resistant/malignant hypertension. It can be described as atherosclerotic or non-atherosclerotic. Atherosclerotic RAS comprises almost 90% of all RAS cases and is a prevalent disease of the eld
Publikováno v:
Cureus
Metabolic acidosis is frequently encountered in the inpatient setting. It can occur due to either the accumulation of endogenous acids that consumes bicarbonate (high anion gap metabolic acidosis) or loss of bicarbonate from the gastrointestinal trac
Publikováno v:
Cureus
Rhabdomyolysis is a clinical syndrome with a wide range of presentations; it results in muscle necrosis and release of intracellular muscle contents into the circulation. Inflammatory myopathies are a rare cause of rhabdomyolysis. We present a case o
Autor:
Adrian Krukowski, Muhammad Shahzad, Arati Kc, Venkata Buddharaju, Ali Azim, Zin Mar Htun, Carlos Salazar, Nilarun Chowdhuri
Publikováno v:
Chest. 156:A1019-A1020
Autor:
Zin Mar Htun, Carlos Salazar, Mohammed El-Dallal, Venkata Buddharaju, Ali Azim, Sandeep Buddharaju, Nilarun Chowdhuri
Publikováno v:
Critical Care Medicine. 47:548
Autor:
Chul Ahn, Venkata Buddharaju, Savneek Chugh, Wilbert S. Aronow, Alan Gass, Anna Koulova, David Spielvogel, Joshua Goldberg, Rudrick Ledesma, Masashi Kai, Ramin Malekan, Maureen Brogan
Publikováno v:
Journal of the American College of Cardiology. 71:A683
The study is designed to look into predictors of poor renal outcomes in patients undergoing VA-ECMO. We analyzed data on adult patients undergoing VA-ECMO and then staged patients with pre- ECMO AKI according to 2012 Kidney Disease Improved Global Ou
Publikováno v:
Current hypertension reports. 15(5)
How chlorthalidone (CTDN) reduces risk for cardiovascular events (CVEs) can be considered in light of its ability to lower blood pressure (BP) and its non-BP related, pleiotropic effects. The mechanism by which CTDN lowers BP is unclear but may inclu